Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Inicio Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) Morphological-metabolic evaluation of the urachal mucinous adenocarcinoma by pos...
Journal Information
Vol. 31. Issue 3.
Pages 145-147 (May - June 2012)
Share
Share
Download PDF
More article options
ePub
Visits
1987
Vol. 31. Issue 3.
Pages 145-147 (May - June 2012)
Clinical note
DOI: 10.1016/j.remnie.2012.03.005
Morphological-metabolic evaluation of the urachal mucinous adenocarcinoma by positron emission tomography-computed tomography (PET-CT)
Evaluación morfo-metabólica del adenocarcinoma mucinoso de uraco mediante tomografía por emisión de positrones-tomografía computarizada (PET-TC)
Visits
...
A.E. Morató-López??
Corresponding author
quique_mla@hotmail.com

Corresponding author.
, M. Corres-Castillo, J. Isusi-Alcazar, N. Reyes-García, O. Quiroz-Castro, J. Serna-Macias
Servicio de PET-CT, Hospital Ángeles del Pedregal, México D.F., Mexico
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Tables (1)
Table 1. Staging of urachal adenocarcinoma (Sheldon's system).
Abstract

The urachal mucinous adenocarcinoma is a rare malignant neoplasm located between the bladder and the umbilicus. It is usually found in an advanced stage at the moment of diagnosis. We have analyzed a clinical case in which the PET-CT study provided valuable morphological and metabolic information for diagnosis and staging.

Keywords:
Positron emission tomography
Computed tomography
Urachal adenocarcinoma
Resumen

El adenocarcinoma mucinoso de uraco es una neoplasia maligna rara, localizada entre la vejiga y el ombligo, y que generalmente se encuentra en estadio avanzado al momento del diagnóstico. Analizamos un caso clínico en el que la PET-TC proporcionó información morfológica y metabólica valiosa para determinar el diagnóstico y la estadificación.

Palabras clave:
Tomografía por emisión de positrones
Tomografía computarizada
Adenocarcinoma de uraco

Article

These are the options to access the full texts of the publication Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Precio 22,50 €

Comprar ahora
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.